Health & Fitness
Health and Fitness
Health and Fitness
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009 AngioDynamics to Participate in the 27th Annual J.P. Morgan Healthcare Conference
QUEENSBURY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 15, 2009 at 10:30 a.m. PT. Eamonn P. Hobbs, president and CEO, and Joseph Gersuk, executive vice president and CFO, of AngioDynamics will review the Company's business strategy and historical financial results.
Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's website at: [ www.angiodynamics.com ].
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation and irreversible electroporation resection systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].
